Effect and Signaling Pathways of Nelumbinis Folium in the Treatment of Hyperlipidemia Assessed by Network Pharmacology

Objective: In this study, the effects and signaling pathways of Nelumbinis folium in the treatment of hyperlipidemia were analyzed based on network pharmacology and molecular docking. Materials and Methods: The main components and targets of Nelumbinis folium were searched through traditional Chines...

Full description

Saved in:
Bibliographic Details
Published inWorld Journal of Traditional Chinese Medicine Vol. 7; no. 4; pp. 445 - 455
Main Authors Pan, Qiu, Zhang, Zhi-Qing, Tian, Cong-Yang, Yu, Tong, Yang, Ran, Chai, Xin-Lou
Format Journal Article
LanguageEnglish
Published Medknow Publications and Media Pvt. Ltd 01.10.2021
Cardiovascular Department,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing,China
Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Cardiovascular Department,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing,China
Wolters Kluwer Medknow Publications
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective: In this study, the effects and signaling pathways of Nelumbinis folium in the treatment of hyperlipidemia were analyzed based on network pharmacology and molecular docking. Materials and Methods: The main components and targets of Nelumbinis folium were searched through traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), and the active components were selected according to their oral availability and drug-like properties. The main targets of hyperlipidemia were identified using the DisGeNET database. Venny 2.1.0 was used to take the intersection of both targets, which were submitted to the STRING database to construct the protein-protein interaction network model. The Database for Annotation, Visualization and Integrated Discovery 6.7 was used to conduct gene ontology and Kyoto Encyclopedia of Gene and Genome pathway enrichment analyses of the targets. Cytoscape 3.7.1 was used to construct the component-target-pathway network. AutoDock Vina molecular docking software was used to study the binding effect and mechanism of the core components and targets of N. folium . Results: Fifteen active components of N. folium and 195 potential targets were selected through TCMSP, whereas 4216 targets for hyperlipidemia were selected from DisGeNET. Further, 138 potential cross-targets of hyperlipidemia were identified. A network of component-target-pathway was constructed. Quercetin, kaempferol, and isorhamnetin were the core components, which played an important role in anti-hyperlipidemia, mainly through the non-alcoholic fatty liver disease and insulin resistance (IR) signaling pathways. Molecular docking results showed that quercetin had the lowest docking energies with peroxisome proliferator activated receptor α, peroxisome proliferator-activated receptor γ, INSR (-6.20,-10.00, and -8.40 (kcal/mol, respectively). The binding mode was mainly hydrogen bonds and van der Waals forces. Conclusions: The active components of N. folium may regulate lipid metabolism by participating in the signaling pathways of non-alcoholic fatty liver disease and IR.
AbstractList Objective: In this study, the effects and signaling pathways of Nelumbinis folium in the treatment of hyperlipidemia were analyzed based on network pharmacology and molecular docking. Materials and Methods: The main components and targets of Nelumbinis folium were searched through traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), and the active components were selected according to their oral availability and drug-like properties. The main targets of hyperlipidemia were identified using the DisGeNET database. Venny 2.1.0 was used to take the intersection of both targets, which were submitted to the STRING database to construct the protein-protein interaction network model. The Database for Annotation, Visualization and Integrated Discovery 6.7 was used to conduct gene ontology and Kyoto Encyclopedia of Gene and Genome pathway enrichment analyses of the targets. Cytoscape 3.7.1 was used to construct the component-target-pathway network. AutoDock Vina molecular docking software was used to study the binding effect and mechanism of the core components and targets of N. folium . Results: Fifteen active components of N. folium and 195 potential targets were selected through TCMSP, whereas 4216 targets for hyperlipidemia were selected from DisGeNET. Further, 138 potential cross-targets of hyperlipidemia were identified. A network of component-target-pathway was constructed. Quercetin, kaempferol, and isorhamnetin were the core components, which played an important role in anti-hyperlipidemia, mainly through the non-alcoholic fatty liver disease and insulin resistance (IR) signaling pathways. Molecular docking results showed that quercetin had the lowest docking energies with peroxisome proliferator activated receptor α, peroxisome proliferator-activated receptor γ, INSR (-6.20,-10.00, and -8.40 (kcal/mol, respectively). The binding mode was mainly hydrogen bonds and van der Waals forces. Conclusions: The active components of N. folium may regulate lipid metabolism by participating in the signaling pathways of non-alcoholic fatty liver disease and IR.
Audience Academic
Author Yang, Ran
Zhang, Zhi-Qing
Chai, Xin-Lou
Yu, Tong
Tian, Cong-Yang
Pan, Qiu
AuthorAffiliation Cardiovascular Department,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing,China;Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Cardiovascular Department,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing,China
AuthorAffiliation_xml – name: Cardiovascular Department,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing,China;Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Cardiovascular Department,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing,China
Author_xml – sequence: 1
  fullname: Pan, Qiu
– sequence: 2
  fullname: Zhang, Zhi-Qing
– sequence: 3
  fullname: Tian, Cong-Yang
– sequence: 4
  fullname: Yu, Tong
– sequence: 5
  fullname: Yang, Ran
– sequence: 6
  fullname: Chai, Xin-Lou
BookMark eNptkt-L1DAQx4uc4Hneu48B34Rd86PtNo_Lcb_g0APP5zBNJt2sbbIkXZfuX29qVRAkgQyTz3xJ5jtviwsfPBbFe0bXJaPiExeMrZpqw9aCNzWTr4pLXjVyxRtZXuT4z_Wb4jqlPaWUbepSVPVl8ePWWtQjAW_IV9d56J3vyDOMuxNMiQRLPmN_HFrnXSJ3oXfHgThPxh2Sl4gwDujHmXqYDhh7d3AGBwdkmxLmbUg7ZYHxFOJ38ryDOIAOfeimd8VrC33C69_nVfHt7vbl5mH19OX-8Wb7tNJlJcZVI6rW1JvSMFPaUmrgIFGYCkSjN1ZaJmRjZUtpA7UpQcuK0xqQVvUGW6obcVU8LromwF4dohsgTiqAU78SIXYK4uh0j6rGVtScmkagKQ1yaaRpsZWIgFXL2qz1cdE6gbfgO7UPx5gbllTan6fpfFbIKWe0zM_J8IcF7iBrO2_DGEEPLmm1rRvKec35TK3_Q-U1d1Fnj63L-X8K6FKgY0gpov37J0bVPApq9lrNXqtlFMRPV-mokw
CitedBy_id crossref_primary_10_1186_s13020_023_00721_z
crossref_primary_10_3233_THC_220908
crossref_primary_10_33549_physiolres_935067
crossref_primary_10_3389_fcvm_2022_927267
crossref_primary_10_1155_2022_4673964
crossref_primary_10_1016_j_jddst_2022_103673
crossref_primary_10_2147_IJWH_S367051
crossref_primary_10_2174_1573409919666230720141115
crossref_primary_10_4103_2311_8571_391113
crossref_primary_10_1002_jsfa_12541
crossref_primary_10_53365_nrfhh_175559
Cites_doi 10.3389/fphar.2021.632236
10.3390/cells9051215
10.3389/fphar.2017.00939
10.1055/s-0031-1279992
10.1371/journal.pone.0118552
10.1002/hep.29367
10.3390/ijms21186902
10.1186/1758-2946-6-13
10.1073/pnas.1016430108
10.1016/j.pharmthera.2009.12.001
10.3390/nu8030167
10.1021/acs.jafc.8b06929
10.1038/nature13477
10.1039/D0FO02135K
10.1080/10408398.2018.1553846
10.1080/01635580903441196
10.1016/j.biopha.2020.110561
10.1016/j.jep.2013.06.034
10.1016/j.bbagrm.2016.03.002
10.1111/jfbc.13034
10.1016/j.biopha.2020.110301
10.3390/cells9112367
10.1007/s13679-017-0261-z
10.1093/nar/gky1049
10.2337/db20-0345
10.1097/MPG.0000000000000279
10.1186/1471-2105-4-2
10.3390/molecules25081975
10.1007/978-3-319-48382-5_8
10.3390/cells9071638
10.1186/s12906-019-2580-y
10.1016/j.jphotobiol.2016.04.006
10.1016/j.jep.2015.08.006
10.1016/j.jceh.2019.06.004
10.1016/S0254-6272(16)30011-5
10.1002/jcc.21334
10.1007/s10787-015-0237-0
10.1039/D0FO02123G
10.1016/j.ijcard.2012.09.085
10.1016/j.biopha.2018.04.016
10.1021/jf101415v
10.1038/s41598-019-52736-y
10.3389/fphar.2020.00528
10.3390/ijms17070999
10.1002/mnfr.201700729
ContentType Journal Article
Copyright COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID AAYXX
CITATION
2B.
4A8
92I
93N
PSX
TCJ
DOA
DOI 10.4103/2311-8571.328619
DatabaseName CrossRef
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2589-2894
EndPage 455
ExternalDocumentID oai_doaj_org_article_6eb3620d83ed4de29d9dbeb9eeae5b1b
sjzyyzz_e202104008
A680226228
10_4103_2311_8571_328619
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: (This work was financially supported by the National Science and Technology Major Project ); (and the National Natural Science Foundation of China )
  funderid: (This work was financially supported by the National Science and Technology Major Project ); (and the National Natural Science Foundation of China )
GroupedDBID -05
-0E
-SE
-S~
2B.
2C~
5VR
5VS
92F
92I
92M
93N
93R
9D9
9DE
AAXDM
AAYXX
ABKZE
ACGFS
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CAJEE
CITATION
EAL
GROUPED_DOAJ
H13
IAO
IHR
INH
IPNFZ
ITC
KQ8
OVD
Q--
RIG
RMW
RT5
T8U
TCJ
TEORI
TGQ
U1F
U1G
U5E
U5O
W3E
WFFXF
CAJUS
4A8
PSX
ID FETCH-LOGICAL-c453t-835bd674d1d4f49ca2a9e3d5a38c7f9f1398f9b008a6d4ac95206ae0567eb0c83
IEDL.DBID DOA
ISSN 2311-8571
IngestDate Tue Oct 22 15:16:03 EDT 2024
Tue Feb 13 23:46:51 EST 2024
Thu Feb 22 23:54:11 EST 2024
Sat Dec 16 00:11:35 EST 2023
Wed Sep 04 12:46:23 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords signaling pathway
hyperlipidemia
Nelumbinis folium
molecular docking
Active components
network pharmacology
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c453t-835bd674d1d4f49ca2a9e3d5a38c7f9f1398f9b008a6d4ac95206ae0567eb0c83
OpenAccessLink https://doaj.org/article/6eb3620d83ed4de29d9dbeb9eeae5b1b
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_6eb3620d83ed4de29d9dbeb9eeae5b1b
wanfang_journals_sjzyyzz_e202104008
gale_infotracmisc_A680226228
gale_infotracacademiconefile_A680226228
crossref_primary_10_4103_2311_8571_328619
PublicationCentury 2000
PublicationDate 2021-10-01
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-01
  day: 01
PublicationDecade 2020
PublicationTitle World Journal of Traditional Chinese Medicine
PublicationTitle_FL World Journal of Traditional Chinese Medicine
PublicationYear 2021
Publisher Medknow Publications and Media Pvt. Ltd
Cardiovascular Department,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing,China
Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Cardiovascular Department,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing,China
Wolters Kluwer Medknow Publications
Publisher_xml – name: Medknow Publications and Media Pvt. Ltd
– name: Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Department of Pharmacology,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,China%Cardiovascular Department,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing,China
– name: Cardiovascular Department,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing,China
– name: Wolters Kluwer Medknow Publications
References Wu (R10-8-20240830) 2010; 58
Sekhon-Loodu (R45-8-20240830) 2015; 23
Yang (R48-8-20240830) 2020; 25
Consortium (R21-8-20240830) 2018; 47
Peirce (R58-8-20240830) 2014; 510
Choudhary (R38-8-20240830) 2019; 9
Brea (R32-8-20240830) 2013; 167
Engin (R56-8-20240830) 2017; 960
Ma (R29-8-20240830) 2013; 7;4
Liu (R6-8-20240830) 2013; 149
Fougerat (R39-8-20240830) 2020; 9
Ru (R20-8-20240830) 2014; 6
Gao (R13-8-20240830) 2019; 36
Laganà (R36-8-20240830) 2016; 17
Ding (R2-8-20240830) 2015; 36
Dan (R17-8-20240830) 2019; 21
Bader (R25-8-20240830) 2003; 4
Chalasani (R33-8-20240830) 2018; 67
Wu (R12-8-20240830) 2017; 8
Wagner (R40-8-20240830) 2020; 9
Sáez-Orellana (R41-8-20240830) 2020; 9
Kobayashi (R61-8-20240830) 2011; 108
Park (R14-8-20240830) 2016; 161
Mbikay (R47-8-20240830) 2018; 62
Wan (R59-8-20240830) 2019; 19
Chen (R23-8-20240830) 2020; 11
Xu (R5-8-20240830) 2021; 12
Jaishree (R46-8-20240830) 2020; 130
Granado-Serrano (R60-8-20240830) 2010; 62
Chung (R8-8-20240830) 2020; 11
Lu (R54-8-20240830) 2018; 103
Trott (R27-8-20240830) 2010; 31
Li (R18-8-20240830) 2011; 36
Chen (R15-8-20240830) 2019; 59
Hoang (R50-8-20240830) 2019; 43
Zhu (R1-8-20240830) 2016; 31
Jiang (R31-8-20240830) 2017; 023
Wagner (R42-8-20240830) 2010; 125
Nobili (R30-8-20240830) 2014; 58
Kim (R7-8-20240830) 2019; 43
Tanaka (R55-8-20240830) 2019; 67
Li (R44-8-20240830) 2016; 8
Włodarski (R57-8-20240830) 2020; 21
Piñero (R22-8-20240830) 2020; 48
Erion (R28-8-20240830) 2017; 6
Chang (R51-8-20240830) 2011; 77
Brierley (R43-8-20240830) 2020; 69
Lee (R11-8-20240830) 2015; 10
Gong (R53-8-20240830) 2020; 128
Cheng (R16-8-20240830) 2019; 50
Lu (R49-8-20240830) 2020; 11
Zhong (R3-8-20240830) 2015; 35
Cave (R37-8-20240830) 2016; 1859
Shi (R35-8-20240830) 2019; 3511
Sharma (R9-8-20240830) 2016; 36
Duan (R19-8-20240830) 2020; 36
Ganbold (R52-8-20240830) 2019; 9
Jiangao (R34-8-20240830) 2016; 32
Kumarihamy (R26-8-20240830) 2015; 174
References_xml – volume: 12
  start-page: 632236
  year: 2021
  ident: R5-8-20240830
  article-title: Nuciferine inhibited the differentiation and lipid accumulation of 3T3-L1 Preadipocytes by regulating the expression of lipogenic genes and adipokines
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.632236
  contributor:
    fullname: Xu
– volume: 36
  start-page: 303
  year: 2020
  ident: R19-8-20240830
  article-title: Application of network pharmacology in the study of traditional Chinese medicine formula
  publication-title: Chin Pharmacol Bull
  contributor:
    fullname: Duan
– volume: 9
  start-page: 1215
  year: 2020
  ident: R41-8-20240830
  article-title: Alzheimer's disease, a lipid story: Involvement of peroxisome proliferator-activated receptor α
  publication-title: Cells
  doi: 10.3390/cells9051215
  contributor:
    fullname: Sáez-Orellana
– volume: 36
  start-page: 71
  year: 2015
  ident: R2-8-20240830
  article-title: Meta analysis of prevalence of dyslipidemia in children and adolescents in China
  publication-title: Chin J Epidemiol
  contributor:
    fullname: Ding
– volume: 21
  start-page: 2397
  year: 2019
  ident: R17-8-20240830
  article-title: Molecular mechanism of ZHIZHU pill in treatment of dyslipidemia based on network pharmacology
  publication-title: World Sci Technol Modernization Trad Chin Med
  contributor:
    fullname: Dan
– volume: 7;4
  start-page: 7
  year: 2013
  ident: R29-8-20240830
  article-title: Effect of hyperlipidemia on systemic immune responses
  publication-title: Chin J Exp Clin Infect Dis (Electronic Edition
  contributor:
    fullname: Ma
– volume: 8
  start-page: 939
  year: 2017
  ident: R12-8-20240830
  article-title: Nuciferine ameliorates inflammatory responses by inhibiting the TLR4-mediated pathway in lipopolysaccharide-induced acute lung injury
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2017.00939
  contributor:
    fullname: Wu
– volume: 77
  start-page: 1876
  year: 2011
  ident: R51-8-20240830
  article-title: Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARα levels
  publication-title: Planta Med
  doi: 10.1055/s-0031-1279992
  contributor:
    fullname: Chang
– volume: 10
  start-page: e0118552
  year: 2015
  ident: R11-8-20240830
  article-title: Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0118552
  contributor:
    fullname: Lee
– volume: 67
  start-page: 328
  year: 2018
  ident: R33-8-20240830
  article-title: The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of liver diseases
  publication-title: Hepatology
  doi: 10.1002/hep.29367
  contributor:
    fullname: Chalasani
– volume: 21
  start-page: 6902
  year: 2020
  ident: R57-8-20240830
  article-title: The role of microRNAs in metabolic syndrome-related oxidative stress
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21186902
  contributor:
    fullname: Włodarski
– volume: 6
  start-page: 13
  year: 2014
  ident: R20-8-20240830
  article-title: TCMSP: A database of systems pharmacology for drug discovery from herbal medicines
  publication-title: J Cheminform
  doi: 10.1186/1758-2946-6-13
  contributor:
    fullname: Ru
– volume: 108
  start-page: 5753
  year: 2011
  ident: R61-8-20240830
  article-title: Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1016430108
  contributor:
    fullname: Kobayashi
– volume: 125
  start-page: 423
  year: 2010
  ident: R42-8-20240830
  article-title: Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2009.12.001
  contributor:
    fullname: Wagner
– volume: 8
  start-page: 167
  year: 2016
  ident: R44-8-20240830
  article-title: Quercetin, inflammation and immunity
  publication-title: Nutrients
  doi: 10.3390/nu8030167
  contributor:
    fullname: Li
– volume: 67
  start-page: 4240
  year: 2019
  ident: R55-8-20240830
  article-title: Comprehensive analyses of quercetin conjugates by LC/MS/MS revealed that isorhamnetin-7- O-glucuronide-4'- O-sulfate is a major metabolite in plasma of rats fed with quercetin glucosides
  publication-title: J Agric Food Chem
  doi: 10.1021/acs.jafc.8b06929
  contributor:
    fullname: Tanaka
– volume: 510
  start-page: 76
  year: 2014
  ident: R58-8-20240830
  article-title: The different shades of fat
  publication-title: Nature
  doi: 10.1038/nature13477
  contributor:
    fullname: Peirce
– volume: 11
  start-page: 8602
  year: 2020
  ident: R8-8-20240830
  article-title: Nelumbo nucifera leaf polyphenol extract and gallic acid inhibit TNF-α-induced vascular smooth muscle cell proliferation and migration involving the regulation of miR-21, miR-143 and miR-145
  publication-title: Food Funct
  doi: 10.1039/D0FO02135K
  contributor:
    fullname: Chung
– volume: 59
  start-page: S189
  year: 2019
  ident: R15-8-20240830
  article-title: Research advances in traditional and modern use of Nelumbo nucifera: Phytochemicals, health promoting activities and beyond
  publication-title: Crit Rev Food Sci Nutr
  doi: 10.1080/10408398.2018.1553846
  contributor:
    fullname: Chen
– volume: 62
  start-page: 390
  year: 2010
  ident: R60-8-20240830
  article-title: Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells
  publication-title: Nutr Cancer
  doi: 10.1080/01635580903441196
  contributor:
    fullname: Granado-Serrano
– volume: 130
  start-page: 110561
  year: 2020
  ident: R46-8-20240830
  article-title: Swertiamarin and quercetin combination ameliorates hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced type 2 diabetes mellitus in wistar rats
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110561
  contributor:
    fullname: Jaishree
– volume: 149
  start-page: 263
  year: 2013
  ident: R6-8-20240830
  article-title: Inhibition of pancreatic lipase, α-glucosidase, α- amylase, and hypolipidemic effects of the total flavonoids from Nelumbo nucifera leaves
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2013.06.034
  contributor:
    fullname: Liu
– volume: 1859
  start-page: 1083
  year: 2016
  ident: R37-8-20240830
  article-title: Nuclear receptors and nonalcoholic fatty liver disease
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagrm.2016.03.002
  contributor:
    fullname: Cave
– volume: 50
  start-page: 1998
  year: 2019
  ident: R16-8-20240830
  article-title: Research progress on chemical constituents and lipid-lowering mechanism of alkaloids in Nelumbinis folium Chinese
  publication-title: Tradit Herbal Drugs
  contributor:
    fullname: Cheng
– volume: 43
  start-page: e13034
  year: 2019
  ident: R50-8-20240830
  article-title: Kaempferol reduces hepatic triglyceride accumulation by inhibiting Akt
  publication-title: J Food Biochem
  doi: 10.1111/jfbc.13034
  contributor:
    fullname: Hoang
– volume: 128
  start-page: 110301
  year: 2020
  ident: R53-8-20240830
  article-title: Isorhamnetin: A review of pharmacological effects
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110301
  contributor:
    fullname: Gong
– volume: 9
  start-page: 2367
  year: 2020
  ident: R40-8-20240830
  article-title: The role of PPARs in disease
  publication-title: Cells
  doi: 10.3390/cells9112367
  contributor:
    fullname: Wagner
– volume: 36
  start-page: 45
  year: 2019
  ident: R13-8-20240830
  article-title: Exploration of the property, officinal parts, and efficacy of “Lian(Lotus)”
  publication-title: Tianjin J Tradit Chin Med
  contributor:
    fullname: Gao
– volume: 6
  start-page: 178
  year: 2017
  ident: R28-8-20240830
  article-title: Hyperinsulinemia: A cause of obesity?
  publication-title: Curr Obes Rep
  doi: 10.1007/s13679-017-0261-z
  contributor:
    fullname: Erion
– volume: 47
  start-page: D506
  year: 2018
  ident: R21-8-20240830
  article-title: UniProt: A worldwide hub of protein knowledge
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gky1049
  contributor:
    fullname: Consortium
– volume: 69
  start-page: 2481
  year: 2020
  ident: R43-8-20240830
  article-title: Anti-insulin receptor antibodies improve hyperglycemia in a mouse model of human insulin receptoropathy
  publication-title: Diabetes
  doi: 10.2337/db20-0345
  contributor:
    fullname: Brierley
– volume: 58
  start-page: 632
  year: 2014
  ident: R30-8-20240830
  article-title: A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/MPG.0000000000000279
  contributor:
    fullname: Nobili
– volume: 4
  start-page: 2
  year: 2003
  ident: R25-8-20240830
  article-title: An automated method for finding molecular complexes in large protein interaction networks
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-4-2
  contributor:
    fullname: Bader
– volume: 25
  start-page: 1975
  year: 2020
  ident: R48-8-20240830
  article-title: Kinetic studies on radical scavenging activity of Kaempferol decreased by Sn(ii) binding
  publication-title: Molecules
  doi: 10.3390/molecules25081975
  contributor:
    fullname: Yang
– volume: 960
  start-page: 197
  year: 2017
  ident: R56-8-20240830
  article-title: What is lipotoxicity?
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-48382-5_8
  contributor:
    fullname: Engin
– volume: 9
  start-page: 1638
  year: 2020
  ident: R39-8-20240830
  article-title: Peroxisome proliferator- activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
  publication-title: Cells
  doi: 10.3390/cells9071638
  contributor:
    fullname: Fougerat
– volume: 43
  start-page: 603
  year: 2019
  ident: R7-8-20240830
  article-title: Anti-obesity effects of Diospyros lotus leaf extract in mice with high-fat diet-induced obesity
  publication-title: Int J Mol Med
  contributor:
    fullname: Kim
– volume: 19
  start-page: 158
  year: 2019
  ident: R59-8-20240830
  article-title: Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms
  publication-title: BMC Complement Altern Med
  doi: 10.1186/s12906-019-2580-y
  contributor:
    fullname: Wan
– volume: 161
  start-page: 211
  year: 2016
  ident: R14-8-20240830
  article-title: Nelumbo nucifera leaf protects against UVB-induced wrinkle formation and loss of subcutaneous fat through suppression of MCP3, IL-6 and IL-8 expression
  publication-title: J Photochem Photobiol B
  doi: 10.1016/j.jphotobiol.2016.04.006
  contributor:
    fullname: Park
– volume: 31
  start-page: 937
  year: 2016
  ident: R1-8-20240830
  article-title: Guidelines for prevention and treatment of dyslipidemia in Chinese adults (revised in 2016)
  publication-title: Chin Circ J
  contributor:
    fullname: Zhu
– volume: 174
  start-page: 57
  year: 2015
  ident: R26-8-20240830
  article-title: In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera flower
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2015.08.006
  contributor:
    fullname: Kumarihamy
– volume: 32
  start-page: 407
  year: 2016
  ident: R34-8-20240830
  article-title: Metabolic syndrome and fatty liver
  publication-title: J Clin Hepatol
  contributor:
    fullname: Jiangao
– volume: 9
  start-page: 731
  year: 2019
  ident: R38-8-20240830
  article-title: Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease
  publication-title: J Clin Exp Hepatol
  doi: 10.1016/j.jceh.2019.06.004
  contributor:
    fullname: Choudhary
– volume: 36
  start-page: 71
  year: 2016
  ident: R9-8-20240830
  article-title: Nelumbo nucifera leaf extract attenuated pancreatic β-cells toxicity induced by interleukin-1β and interferon-γ, and increased insulin secrection of pancreatic β-cells in streptozotocin-induced diabetic rats
  publication-title: J Tradit Chin Med
  doi: 10.1016/S0254-6272(16)30011-5
  contributor:
    fullname: Sharma
– volume: 023
  start-page: 1705
  year: 2017
  ident: R31-8-20240830
  article-title: Comparative study on the anti atherosclerosis function of Huo Xue recipe and Yang He decoction in apoE - / - Mice combined with nonalcoholic fatty liver disease
  publication-title: J Basic Chin Med
  contributor:
    fullname: Jiang
– volume: 3511
  start-page: 1
  year: 2019
  ident: R35-8-20240830
  article-title: Expert recommendations on standardized diagnosis and treatment for fatty liver disease(2019 revised edition)
  publication-title: J Clin Hepatol
  contributor:
    fullname: Shi
– volume: 31
  start-page: 455
  year: 2010
  ident: R27-8-20240830
  article-title: AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
  publication-title: J Comput Chem
  doi: 10.1002/jcc.21334
  contributor:
    fullname: Trott
– volume: 23
  start-page: 173
  year: 2015
  ident: R45-8-20240830
  article-title: Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia
  publication-title: Inflammopharmacology
  doi: 10.1007/s10787-015-0237-0
  contributor:
    fullname: Sekhon-Loodu
– volume: 11
  start-page: 10058
  year: 2020
  ident: R49-8-20240830
  article-title: Integrative transcriptomics and metabolomics explore the mechanism of kaempferol on improving nonalcoholic steatohepatitis
  publication-title: Food Funct
  doi: 10.1039/D0FO02123G
  contributor:
    fullname: Lu
– volume: 167
  start-page: 1109
  year: 2013
  ident: R32-8-20240830
  article-title: Non-alcoholic fatty liver disease and cardiovascular risk
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2012.09.085
  contributor:
    fullname: Brea
– volume: 103
  start-page: 800
  year: 2018
  ident: R54-8-20240830
  article-title: Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/ PPAR-a pathway in mice
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.04.016
  contributor:
    fullname: Lu
– volume: 58
  start-page: 7075
  year: 2010
  ident: R10-8-20240830
  article-title: Improvement in high-fat diet-induced obesity and body fat accumulation by a Nelumbo nucifera leaf flavonoid-rich extract in mice
  publication-title: J Agric Food Chem
  doi: 10.1021/jf101415v
  contributor:
    fullname: Wu
– volume: 9
  start-page: 16210
  year: 2019
  ident: R52-8-20240830
  article-title: Isorhamnetin alleviates steatosis and fibrosis in mice with nonalcoholic steatohepatitis
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-52736-y
  contributor:
    fullname: Ganbold
– volume: 48
  start-page: D845
  year: 2020
  ident: R22-8-20240830
  article-title: The DisGeNET knowledge platform for disease genomics: 2019 update
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Piñero
– volume: 11
  start-page: 528
  year: 2020
  ident: R23-8-20240830
  article-title: Investigation of the lipid-lowering mechanisms and active ingredients of Danhe granule on hyperlipidemia based on systems Pharmacology
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2020.00528
  contributor:
    fullname: Chen
– volume: 17
  start-page: E999
  year: 2016
  ident: R36-8-20240830
  article-title: Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: Current evidence and future perspectives
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17070999
  contributor:
    fullname: Laganà
– volume: 36
  start-page: 2017
  year: 2011
  ident: R18-8-20240830
  article-title: Network target: A starting point for traditional Chinese medicine network pharmacology
  publication-title: China J Chin Mater Med
  contributor:
    fullname: Li
– volume: 62
  start-page: e1700729
  year: 2018
  ident: R47-8-20240830
  article-title: Mice fed a high-cholesterol diet supplemented with quercetin-3-glucoside show attenuated hyperlipidemia and hyperinsulinemia associated with differential regulation of PCSK9 and LDLR in their liver and pancreas
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201700729
  contributor:
    fullname: Mbikay
– volume: 35
  start-page: 64
  year: 2015
  ident: R3-8-20240830
  article-title: Using Drug Regularity Investigation of 140 Hypolipidemic Chinese Medicines in the Treatment of Hyperlipidemia
  publication-title: Journal of Hunan Univ of CM
  contributor:
    fullname: Zhong
SSID ssj0001764356
Score 2.2915196
Snippet Objective: In this study, the effects and signaling pathways of Nelumbinis folium in the treatment of hyperlipidemia were analyzed based on network...
SourceID doaj
wanfang
gale
crossref
SourceType Open Website
Aggregation Database
StartPage 445
SubjectTerms active components
Care and treatment
Chemical properties
Development and progression
Health aspects
Hyperlipidemia
Lotus
molecular docking
nelumbinis folium
network pharmacology
Physiological aspects
Phytochemicals
signaling pathway
Title Effect and Signaling Pathways of Nelumbinis Folium in the Treatment of Hyperlipidemia Assessed by Network Pharmacology
URI https://d.wanfangdata.com.cn/periodical/sjzyyzz-e202104008
https://doaj.org/article/6eb3620d83ed4de29d9dbeb9eeae5b1b
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA5SUHwRr7haJaAgPoydSTK5PFZxWYSWgi30LZzclpU6K7tby-yv92QyXbdPvviaCSF8OTn5zuTkO4S8D4lpYN5ULkCqhDCpMuAwWPFIHgLy5XZ4x31yKmcX4ttle7lX6ivnhBV54ALckcRoT7I6aB6DCJGZYIKLzsQIsXWNG7xvbfaCqeHvisKTti2V5Zqm0q1qyh2laGp-tGv7xJmWWWRn70wapPt3Dvr-DXQJuvneoTN9TB6NbJEel1k-Ifdi95Q8OBnvw5-R30V8mEIX6PfFPJPqbk7PkNXdQL-my0RPI3ofl_VD6HR5tbj-SRcdRdJHz28zzHOvGUajq6tFqRYLtNwEx0BdjwMMeeL07K_Gdf-cXEy_nn-ZVWMlhcqLlm8qpFkuSCVCE0QSxgMDE3logWuvkklIA3XK6ogaZBDgTctqCRHJkYqu9pq_IAfdsosvCY1eet6kpB2AqKMyiSv0CkphYKVaAxPy8RZL-6sIZlgMNDLuNuNuM-624D4hnzPYu35Z6npoQAOwowHYfxnAhHzIS2XzhtyswMP4rgCnm6Wt7LHMr4klY3pCDu_0xI3k73x-Ny62Hffx2q5_bPt-u7WR5dgY_Z1-9T_m_Jo8zAOWpMBDcrBZXcc3SG427u1gx38ATYn3Rg
link.rule.ids 315,783,787,867,2109,27937,27938
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+and+Signaling+Pathways+of+Nelumbinis+Folium+in+the+Treatment+of+Hyperlipidemia+Assessed+by+Network+Pharmacology&rft.jtitle=%E4%B8%96%E7%95%8C%E4%B8%AD%E5%8C%BB%E8%8D%AF%E6%9D%82%E5%BF%97%EF%BC%88%E8%8B%B1%E6%96%87%E7%89%88%EF%BC%89&rft.au=Qiu+Pan&rft.au=Zhi-Qing+Zhang&rft.au=Cong-Yang+Tian&rft.au=Tong+Yu&rft.date=2021-10-01&rft.pub=Cardiovascular+Department%2CXiyuan+Hospital%2CChina+Academy+of+Chinese+Medical+Sciences%2CBeijing%2CChina&rft.issn=2311-8571&rft.eissn=2589-2894&rft.volume=7&rft.issue=4&rft.spage=445&rft.epage=455&rft_id=info:doi/10.4103%2F2311-8571.328619&rft.externalDocID=sjzyyzz_e202104008
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fsjzyyzz-e%2Fsjzyyzz-e.jpg